Morpholine → HCID 59563522, Verbindung
Reaktionsgleichung
[NH2:1][C:2]1[C:11]2[N:12]=[C:13]([CH2:35][CH2:36][CH2:37][CH3:38])[N:14]([CH2:15][CH2:16][CH2:17][N:18]([CH2:23][C:24]3[CH:25]=[C:26]([CH2:30][C:31]([O:33][CH3:34])=[O:32])[CH:27]=[CH:28][CH:29]=3)[CH2:19][CH2:20][CH2:21]Cl)[C:10]=2[C:9]2[CH:8]=[CH:7][CH:6]=[CH:5][C:4]=2[N:3]=1.[NH:39]1[CH2:44][CH2:43][O:42][CH2:41][CH2:40]1>>[NH2:1][C:2]1[C:11]2[N:12]=[C:13]([CH2:35][CH2:36][CH2:37][CH3:38])[N:14]([CH2:15][CH2:16][CH2:17][N:18]([CH2:23][C:24]3[CH:25]=[C:26]([CH2:30][C:31]([O:33][CH3:34])=[O:32])[CH:27]=[CH:28][CH:29]=3)[CH2:19][CH2:20][CH2:21][N:39]3[CH2:44][CH2:43][O:42][CH2:41][CH2:40]3)[C:10]=2[C:9]2[CH:8]=[CH:7][CH:6]=[CH:5][C:4]=2[N:3]=1Komponenten
3
Versuchsvorschrift
The title compound was prepared by the method of example 11 step (x) using the product from example 11 step (ix) (627 mg) and morpholine (1 ml) to give product as a white solid 165 mg.
Quellen und Nachweise
- ORD-Eintrag
- ord-e819715e660a45bcbbdb41f2943e8772
- Quelldatensatz
- uspto-grants-2013_05